Joana Miranda, PhD
FFUL - Faculdade de Farmácia da Universidade de Lisboa
Joana Miranda has a PhD degree in Biochemistry/Biotechnology from ITQB NOVA Lisboa. In 2009 Joana Miranda joined FFULas an assistant researcher and since 2018 is an assistant professor at the FFUL (https://www.ff.ulisboa.pt/equipa/joana-paiva-gomes-miranda/) and Heads a research group at iMed.ULisboa. She works in the field of tissue engineering and alternative methods for drug testing, with research focusing on the development of 3D in vitro cultures of hepatocytes or human MSCs for in vitro toxicology and cell therapy applications, publishing in the field for almost 15 years. In particular, 3D hepatocytes and human HLC cultures are used for drug safety and biotransformation studies. In addition, aggregation strategies of MSCs are also employed for priming cells towards an enhanced potential for cellular therapies such as skin regeneration and rheumatoid arthritis. Joana Miranda is a member of the Sociedade Portuguesa de Farmacologia (SPF) and Sociedade Portuguesa de Células Estaminais e Terapia Celular (SPCE-TC). Currently, she is the Coordinator of the Toxicology Section of SPF and of the Portuguese Register of Toxicologists (ERT – European Registered Toxicologist – EUROTOX). Since 2010 Joana Miranda has participated in 11 funded projects (5 as PI). She also authored over 47 peer-reviewed articles, 4 patents, 5 book chapters, 43 published abstracts, 11 invited lectures, 60 oral communications and 95 posters.